Table 5.
Case 5. AFP, L3%, ALT, and imaging findings at time of HCC screening, diagnosis, and at various treatment points.
| Date | AFP (ng/mL) | AFP-L3 (%) | ALT (IU/mL) | MRI | HCC Treatment |
|---|---|---|---|---|---|
| May 2008 | 3.2 | 13.8 | 32 | No tumor | |
| August 2008 | 3.2 | 33.6 | 20 | July 2008 (Figure 4A,B) Indeterminate | |
| November 2008 | 7.9 | 69.7 | 30 | No tumor visualized | |
| March 2009 | 24.1 | 87.7 | 17 | 2.4 × 2.0 HCC (Figure 5A–C) |
|
| March 2009 | 16.6 | 88.8 | 23 | HCC | |
| April 2009 May 2009 |
Cryoablation (Figure 6A,B) |
||||
| August 2009 July 2010 |
6.7 | 74.7 | 20 (8/17/09) | new HCC (Figure 7A–D) |
RFA, TACE |